(Press-News.org) In August 2024, the World Health Organization declared a second “Public Health Emergency of International Concern” for mpox. The current outbreak in Africa is driven mainly by the clade I variant, with multiple countries reporting their first-ever mpox cases of this more severe strain. Nagoya University researchers and their collaborators have found that measuring the amount of virus in the blood when skin lesions first appear can help predict whether patients will experience mild or severe progression of the disease. The study analyzes viral loads during early infection to predict how sick patients will get, potentially improving treatment strategies for future outbreaks.
Mpox virus causes distinctive rash and flu-like symptoms. It spreads mainly through direct contact with skin lesions, so patients must avoid contact with others until these completely heal. Skin lesions change dramatically over time and vary among patients, making it difficult to predict when someone is no longer contagious.
There are two strains of the virus: clade I (with subclades Ia and Ib) and clade II (with subclades IIa and IIb). The research team analyzed medical records from 2007 to 2011 from clade Ia mpox patients in the Democratic Republic of the Congo, the most affected country. They analyzed the amount of virus present in patients’ blood when skin lesions first developed and tracked how their lesions changed over time. Patterns in the data were studied to see if patients could be grouped based on how long skin lesions took to heal and how severe their symptoms became.
According to co-lead author, Shingo Iwami, professor at the Nagoya University Graduate School of Science, patients with blood viral levels above a specific threshold when skin lesions start to appear—about 40 000 viral copies per milliliter—are at higher risk of developing severe, long-lasting symptoms, which may also be associated with a longer period of infectiousness.
“Our findings suggest patients naturally fall into two distinct groups: those with mild cases who recover relatively quickly, and those with severe symptoms where skin lesions persist for weeks. By combining math modelling and machine learning, we identified a specific threshold that reliably predicts which group a patient belongs to.”
The clade Ia strain has a mortality rate of about 10%, substantially higher than the 1% mortality rate of clade IIb during the 2022 global outbreak. However, the current outbreak, extending from the Democratic Republic of the Congo to neighboring countries, involves clade Ib in addition to clade Ia. Testing the method on the clade Ib variant will be the focus of the team’s future research.
Predicting disease severity early could help doctors provide intensive treatment and monitoring for mpox patients expected to have severe cases, as well as more attentive monitoring protocols compared to those with milder predicted outcomes.
“If this method can be applied to current circulating mpox strains, we can move toward more personalized, data-driven medicine. For patients and their families, this could provide clearer expectations about recovery timelines and reassurance through more precise medical predictions after a frightening diagnosis,” Professor Iwami noted.
The study, “Modeling lesion transition dynamics to clinically characterize patients with clade I mpox in the Democratic Republic of the Congo,” was published in the journal Science Translational Medicine, on July 2, 2025, at DOI: 10.1126/scitranslmed.ads4773.
More information, including a copy of the paper, can be found online at the Science Translational Medicine press package at https://www.eurekalert.org/press/medpak/.
END
Using viral load tests to help predict mpox severity when skin lesions first appear
Study identifies which patients will develop severe, long-lasting skin lesions, enabling more targeted infection-control measures.
2025-07-02
ELSE PRESS RELEASES FROM THIS DATE:
Engineered cell cross-talk unlocks CAR-T potential against glioblastoma
2025-07-02
A team of researchers from the San Raffaele-Telethon Institute for Gene Therapy (SR-TIGET, Milan), led by Nadia Coltella and Luigi Naldini, has unveiled a powerful strategy to rejuvenate the effectiveness of chimeric antigen receptor (CAR) T cell therapy against glioblastoma, one of the most lethal and treatment-resistant brain tumors. The findings, published in Science Translational Medicine, highlight how gene therapy targeting immune stimulating cytokines to the tumor microenvironment (TME) and enabling their private cross-talk with CAR-T cells not only restores CAR-T killer activity but also boost a broader immune response that inhibits tumor growth and extends host ...
Regional disparities in US media coverage of archaeology research
2025-07-02
What archaeological discoveries are considered newsworthy by U.S. media outlets and audiences? A new analysis of “pop-science” reporting reveals topical and regional disparities, including an apparent underrepresentation of Chinese archaeology and preference for findings relevant to white Christian histories. The skewed coverage raises concerns as archaeology influences notions of identity and cultural achievement, and has been misappropriated by racist, nationalist ideologies.
Mass ...
Coral larvae travelling further makes populations stronger
2025-07-02
Understanding how far Great Barrier Reef corals are from their parents could be key to identifying and protecting at risk populations, University of Queensland research has found.
PhD candidate Zoe Meziere said well-connected coral populations had a better chance of adapting to climate change and other environmental pressures.
“Quantifying genetic connectivity can predict the fate of populations as more isolated reefs with lower levels of genetic variation are likely more vulnerable,” Ms Meziere said.
“Species that don’t disperse or breed as far are more likely to form isolated populations, reducing their capacity to recover from bleaching events ...
First of its kind study for children with arthritis reveals possible new disease targets
2025-07-02
A new groundbreaking study by researchers from University of Birmingham, UCL, Great Ormond Street Hospital and Birmingham Children’s Hospital has revealed important clues into what is driving disease in children with arthritis.
Cutting-edge techniques have allowed scientists for the first time to uncover the unique architecture of cells and signals inside the joint as inflammation takes hold.
The new study published in Science Translational Medicine looks at arthritis in children, caused by the immune system mistakenly attacking joints. Juvenile idiopathic arthritis affects more than 10,000 children in the UK. It causes swelling, ...
Financing innovation: proposal for novel adaptive platform trial fund offers new model for ALS drug development
2025-07-02
A team of researchers from the MIT Sloan School of Management, the Sean M. Healey & AMG Center for ALS at Massachusetts General Hospital (MGH), Questrom School of Business at Boston University, and QLS Advisors have introduced a new approach to funding clinical trials for amyotrophic lateral sclerosis (ALS) therapies. The study “Financing Drug Development via Adaptive Platform Trials,” published today in PLOS One, outlines a financing model that merges the efficiencies of adaptive platform trials — lower costs and shorter durations — with an innovative royalty-based investment structure designed to accelerate therapeutic development ...
Disparities in treatment and referral after an opioid overdose among emergency department patients
2025-07-02
About The Study: In this study, Black patients were less likely to receive outpatient referrals for opioid use disorder. These findings underscore the need for targeted interventions to address racial disparities in emergency department care for opioid use disorder, particularly in enhancing referral processes.
Corresponding Author: To contact the corresponding author, Siri Shastry, MD, MS, email Siri.Shastry@mountsinai.org.
To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/
(doi:10.1001/jamanetworkopen.2025.18569)
Editor’s Note: Please ...
Was Mars doomed to be a desert? Study proposes new explanation
2025-07-02
One of the great unsolved problems in modern planetary science is written on the surface of Mars.
Mars has canyons that were carved by rivers, so it was once warm enough for liquid water. How—and why—did it become it a barren desert today?
A study led by University of Chicago planetary scientist Edwin Kite puts forth a new explanation for why Mars never seems to stay balmy for long. Published July 2 in Nature, their model suggests that the periods of liquid water we see in the past were initiated by the sun brightening, and that conditions on Mars mean it ...
Study highlights major hurdles for multinational clinical trials in Europe
2025-07-02
Study Highlights Major Hurdles for Multinational Clinical Trials in Europe
A new study by investigators from Europe, including the Netherlands and the United Kingdom (UK), has shed light on significant ethical, administrative, regulatory, and logistical (EARL) hurdles in delivering multinational randomized clinical trials. The research was the first to comprehensively quantify these barriers for an international platform trial and emphasizes the need for urgent improvements, particularly in preparing for future public health crises.
Randomized controlled trials provide the highest level of evidence to inform medical practice. Yet, delivering such trials ...
Chemistry breakthrough has potential to make more effective cancer drugs with less harmful side effects
2025-07-02
Chemists have discovered for the first time a unique way to control and modify a type of compound widely used in medicines, including a drug used to treat breast cancer.
The research, led by the University of Bristol and published today in the journal Nature, also found a new mechanism associated with the chemical reaction which enables the shape of the compound to be flipped from being right-handed to left-handed by simply adding a common agent in the chemical reaction.
Study lead author Varinder Aggarwal, Professor of Synthetic Chemistry at the University of Bristol, said: “The findings change our understanding of the fundamental chemistry of this group of organic ...
Researchers identify new protein target to control chronic inflammation
2025-07-02
Chronic inflammation occurs when the immune system is stuck in attack-mode, sending cell after cell to defend and repair the body for months or even years. Diseases associated with chronic inflammation, like arthritis or cancer or autoimmune disorders, weigh heavily on human health—and experts anticipate their incidence is on the rise. A new study by investigators from Mass General Brigham identified a protein called WSTF that could be targeted to block chronic inflammation. Crucially, this strategy would not ...
LAST 30 PRESS RELEASES:
Vaccination support program reduces pneumonia-related mortality by 25 percent among the elderly
Over decades, a healthy lifestyle outperforms metformin in preventing onset of Type 2 diabetes
Mental health disorders, malaria, and heart disease most affected by covid pandemic
Green transition will boost UK productivity
Billions voted in 2024, but major new report exposes cracks in global democracy
Researchers find “forever chemicals” impact the developing male brain
Quantum leap in precision sensing across technologies
Upgrading biocrude oil into sustainable aviation fuel using zeolite-supported iron-molybdenum carbide nanocatalysts
For effective science communication, ‘just the facts’ isn’t good enough
RT-EZ: A golden gate assembly toolkit for streamlined genetic engineering of rhodotorula toruloides
Stem Cell Reports announces five new early career editors
Support networks may be the missing link for college students who seek help for excessive drinking
The New England Journal of Medicine shines spotlight on forensic pathology
Scientists discover protein that helps lung cancer spread to the brain
Perceived social status tied to cardiovascular risks in women but not in men
Brain tumor growth patterns may help inform patient care management
This might be America's first campus tree inventory
Emoji use may impact relationship outcomes
Individual merit, not solidarity, prioritized by early childhood education policies
Preclinical study unlocks a mystery of rapid mouth healing
Extraterrestrial habitats: bioplastics for life beyond earth
U.S. military spending reductions could substantially lower energy consumption
Air pollution is linked to adverse birth outcomes in India
Using viral load tests to help predict mpox severity when skin lesions first appear
Engineered cell cross-talk unlocks CAR-T potential against glioblastoma
Regional disparities in US media coverage of archaeology research
Coral larvae travelling further makes populations stronger
First of its kind study for children with arthritis reveals possible new disease targets
Financing innovation: proposal for novel adaptive platform trial fund offers new model for ALS drug development
Disparities in treatment and referral after an opioid overdose among emergency department patients
[Press-News.org] Using viral load tests to help predict mpox severity when skin lesions first appearStudy identifies which patients will develop severe, long-lasting skin lesions, enabling more targeted infection-control measures.